A reasonable voice from Switzerland that was published on YAHOO from the ink that Dickwit provided:
Frank4 minutes ago
The loss today at the Swiss market is entirely related to the sad loss of Tommy S. In my view he got VIP too late, when the damage of the virus and even more of the disturbed immune system with its cytokine storm was already done - especially on the small vessels that finallycould not maintain anymore the right balance between the interceullar fluid and the blood. All inflammatory markers got normal after VIP infusion and also the Covid-19 for viral RNA was negative (no virus anymore). I conclude: that the drug worked very well, but should be given as early as possible. The drug did its job very well, but it given too late. Once you had a severe car accident because of bad functioning breaks it is also too late to repair the breaks (even of the repair was done well). Very sad for Tommy and his family. Bad story.
The stock market yesterday and today in Switzerland reflects this sad loss. Today small investors who now have doubt about the efficacy of VIP are selling. Big mistake in my view, remember, Tommy's illness was already to advanced and severe that he could not be anymore enrolled in studies with "critical" Covid-19 infections ("critical" is already most advanced and sever stage that is studied).
I would not even say that the efficacy of RLF-100 has its limits - because it did also in Tommy what it is supposed to do (calm the cytokine storm and clear the body from this virus). This said death just shows: it is not directly the virus that kills but it is the damage caused by the disturbed immune system. Once such severe damage has been made, it is very difficult if not impossible to save the life.
However, it does not change the efficacy of RLF-100. Remember such severe cases are NOT enrolled by the phase II/III study - thus such cases will not impact the outcome of this study.
Today some small investors who have not studied well this blockbuster drug are selling. This will be short lived. Larger investors and those familiar with the science and results so far obtained keep their shares or are even using the dip today to increase position (I did so a few minutes ago).
